Cyclacel Limited

ANGIOCYCLIC

EDUCATIONAL SERVICES, NAMELY, PROVIDING CLASSES, SEMINARS, LECTURES AND COMPUTER EDUCATION TRAINING, ALL RELATING TO SCIENTIFIC RESEARCH, MEDICAL RESEARCH, DRUG RESEARCH AND DRUG DEVELOPMENT TECHNOLOGY IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; EDUCATIONAL SERVICES, NAMELY, PROVIDING CLASSES, SEMINARS, LECTURES AND COMPUTER EDUCATION TRAINING FOR THE COMPILATION OF SCIENTIFIC INFORMATION AND USE OF SCIENTIFIC MATERIALS FROM DATABASES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES;PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; BIOPHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; CHEMICAL PREPARATIONS AND SUBSTANCES FOR PHARMACEUTICAL, BIOPHARMACEUTICAL AND MEDICAL PURPOSES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; DRUGS FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; DRUGS FOR MEDICAL PURPOSES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; MEDICAL THERAPEUTIC DRUGS FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES;MEDICAL SERVICES; COMPILATION OF MEDICAL, PHARMACEUTICAL AND BIOPHARMACEUTICAL INFORMATION FOR DIAGNOSTIC PURPOSES AND EXCLUDING MEDICAL, PHARMACEUTICAL AND BIOPHARMACEUTICAL RESEARCH INFORMATION; AND PROVIDING ONLINE MEDICAL, PHARMACEUTICAL AND BIOPHARMACEUTICAL INFORMATION FOR DIAGNOSTIC PURPOSES;SCIENTIFIC RESEARCH SERVICES AND LABORATORY RESEARCH SERVICES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; COMPILATION OF SCIENTIFIC INFORMATION FOR SCIENTIFIC OR FOR SCIENTIFIC RESEARCH SERVICES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; MEDICAL RESEARCH AND LABORATORY RESEARCH SERVICES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; PROVIDING ONLINE SCIENTIFIC INFORMATION IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; DRUG RESEARCH SERVICES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; DEVELOPMENT OF PHARMACEUTICAL DRUGS, DRUGS FOR MEDICAL PURPOSES AND MEDICAL THERAPEUTIC DRUGS;

ANGIOMITOTIC

EDUCATIONAL SERVICES, NAMELY, PROVIDING CLASSES, SEMINARS, LECTURES AND COMPUTER EDUCATION TRAINING, ALL RELATING TO SCIENTIFIC RESEARCH, MEDICAL RESEARCH, DRUG RESEARCH AND DRUG DEVELOPMENT TECHNOLOGY IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; EDUCATIONAL SERVICES, NAMELY, PROVIDING CLASSES, SEMINARS, LECTURES AND COMPUTER EDUCATION TRAINING FOR THE COMPILATION OF SCIENTIFIC INFORMATION AND USE OF SCIENTIFIC MATERIALS FROM DATABASES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES;PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; BIOPHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; CHEMICAL PREPARATIONS AND SUBSTANCES FOR PHARMACEUTICAL, BIOPHARMACEUTICAL AND MEDICAL PURPOSES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; DRUGS FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; DRUGS FOR MEDICAL PURPOSES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; MEDICAL THERAPEUTIC DRUGS FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES;MEDICAL SERVICES; COMPILATION OF MEDICAL, PHARMACEUTICAL AND BIOPHARMACEUTICAL INFORMATION FOR DIAGNOSTIC PURPOSES AND EXCLUDING MEDICAL, PHARMACEUTICAL AND BIOPHARMACEUTICAL RESEARCH INFORMATION; AND PROVIDING ONLINE MEDICAL, PHARMACEUTICAL AND BIOPHARMACEUTICAL INFORMATION FOR DIAGNOSTIC PURPOSES;SCIENTIFIC RESEARCH SERVICES AND LABORATORY RESEARCH SERVICES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; COMPILATION OF SCIENTIFIC INFORMATION FOR SCIENTIFIC OR FOR SCIENTIFIC RESEARCH SERVICES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; MEDICAL RESEARCH AND LABORATORY RESEARCH SERVICES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; PROVIDING ONLINE SCIENTIFIC INFORMATION IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; DRUG RESEARCH SERVICES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; DEVELOPMENT OF PHARMACEUTICAL DRUGS, DRUGS FOR MEDICAL PURPOSES AND MEDICAL THERAPEUTIC DRUGS;

C CYCLACEL

The mark consists of the word CYCLACEL shown in black with a highly stylized letter C comprised of five curved bands shown in light blue with seven black graduated dots.;Pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical substances and preparations for the treatment of cancer, hematological disorders; pharmaceutical substances and preparations for use in oncology, hematology; medical preparations for the treatment of cancer and hematological disorders; medical substances in the nature of pharmaceuticals for the treatment of oncological diseases and preparations for use in oncology; medicinal preparations for the treatment of cancer and hematological disorders; medical substances in the nature of pharmaceuticals for the treatment of cancer and hematological disorders; preparations for human use for the treatment of cancer and hematological disorders;The color(s) light blue and black is/are claimed as a feature of the mark.;The wording CYCLACEL has no meaning in a foreign language.;Pharmaceutical development; pharmaceutical products development; development of pharmaceuticals for the treatment of cancer; development of products for the treatment of cancer; development of pharmaceuticals for the treatment of leukemia; development of pharmaceuticals for the treatment of hematological cancers; development of products for the treatment of leukemia; development of products for the treatment of hematological cancers;